Clinical Trial

Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to investigate the relationship between sleep quality, cognitive functions, and disease severity in individuals with Parkinson's disease. The main question it aims to answer is: Is sleep quality associated with cognitive function and disease severity in individuals with Parkinson's disease? Participants will complete assessments of sleep quality, cognitive function, disease severity, and disease stage during a single evaluation session. Cognitive function will be evaluated using the Stroop Test, Clock Drawing Test, and Montreal Cognitive Assessment. Disease severity will be assessed using the Unified Parkinson's Disease Rating Scale, and disease stage will be determined using the Modified Hoehn and Yahr Scale.
Protocol Amendment History 4 changes
critical Trial completed 2026-06-17
notable Primary completion moved earlier: 2026-08-15 -> 2026-06-01 2026-06-17
minor Completion moved earlier: 2026-09-15 -> 2026-06-10 2026-06-17
critical Recruitment opened 2026-06-03
Trial Details
NCT Number NCT07536490
Lead Sponsor Ankara University
Collaborators: Hacettepe University
Conditions Parkinson Disease
Enrollment 69 participants
Start Date 2026-05-10
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-16